akhila
Spinal Cord Stimulation Devices Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2024
Spinal Cord Stimulation Devices Market:
By Product Type (Rechargeable Devices and Non-Rechargeable Devices), By Application (Failed Back Surgery Syndrome (FBSS), Complex Regional Pain Syndrome (CRPS), Ischemic Pain, and Others), By End User (Hospitals, Ambulatory Surgical Centers, and Neuro Clinics), and Geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2024
Spinal Cord Stimulation Devices Market Report Description:
Global Spinal Cord Stimulation Devices market report gives comprehensive outlook on spinal card stimulation devices across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on spinal cord stimulation devices market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, application, end user, and geographic regions. This report studies spinal cord stimulation devices market dynamics elaborately to identify the current market trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, spinal cord stimulation devices market report includes the competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed spinal cord stimulation devices market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs. Key stakeholders of the spinal cord stimulation devices market report include raw material suppliers, OEMs, spinal cord stimulation device marketers, hospitals, physician offices, policy makers, and healthcare service providers who are engaged in usage and advocacy of Spinal Cord Stimulation Devices.
A sample of this report is available upon request @
Spinal Cord Stimulation Devices Market:
Global spinal cord stimulation devices market was valued at US$ 1,850 Mn in 2016 and poised to grow around 9% CAGR over 2017-2023.
To view TOC of this report is available upon request @
Competition Assessment
Key players profiles in the global spinal cord stimulation devices market include:
- Boston Scientific and corporation
- Greatbatch
- Medtronic plc.
- Nevro corp.
- Jude Medical
- Stimwave
Players in the spinal cord stimulation devices market are entering into partnerships, collaborations, and acquiring smaller players to garner larger market share
Need more information about this report @
Key Features of the Report:
- The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2024)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Detailed Segmentation
By Product Type
- Rechargeable Devices
- Non-Rechargeable Devices
By Application
- Failed Back Surgery Syndrome (FBSS)
- Complex Regional Pain Syndrome (CRPS)
- Ischemic Pain
- Others
By End User
- Hospitals
- Ambulatory Surgical Centers
- Neuro Clinics
Geography
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia & New Zealand
- ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Venezuela
- Rest of Latin America
- Middle East and Africa (MEA)
- Gulf Cooperation Council (GCC) Countries
- Israel
- South Africa
- Rest of MEA
Get access to full summary @
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.
Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
Global Soft Tissue Sarcoma Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
Soft tissue sarcoma treatment market: Soft tissue sarcoma is the rare and diverse group of cancers that develop from soft tissues such as blood vessels, muscles, fats, nerves, and deep skin tissues etc. There are around 50 different types of soft tissue sarcoma have been identified, the common types of soft tissue sarcoma are liposarcomas which develop from fat cells, and leiomyosarcomas, which arise from smooth muscle tissue. The soft tissue sarcoma can be treated by the combined chemotherapy, radiotherapy, and surgery to remove the tumour. If surgical procedure is not required, chemotherapy alone can be used.
Global Market Outline: Soft Tissue Sarcoma Treatment Market
Increase in the prevalence and incidence of different types of cancers, rise in the number of soft tissue sarcoma cases, increase in the R&D activities on drugs and other biological therapies, patent expiry of branded drugs, increase in the healthcare expenditure and rise in quality patient care are expected to fuel the soft tissue sarcoma treatment market over the forecast period. However, high cost for the radiotherapy and chemotherapy, stringent regulatory guidelines, and adverse effects associated with the treatment might hinder the growth of soft tissue sarcoma treatment market over the forecast timeframe.
A sample of this report is available upon request @
The soft tissue sarcoma treatment market has been segmented on basis of disease type, treatment type, and end user
Based on the treatment type, soft tissue sarcoma treatment market is segmented into following:
- Targeted Therapy
- Chemotherapy
- Anti-angiogenesis drugs
- Radiation Therapy
- Internal Radiation Therapy
- External Radiation Therapy
Based on the disease type, soft tissue sarcoma treatment market is segmented into following:
- Local Sarcoma
- Regional Sarcoma
- Metastatic Sarcoma
Based on the distribution channel, soft tissue sarcoma treatment market is segmented into following:
- Hospitals
- Oncology Clinics
- Long Term Care Centres
To view TOC of this report is available upon request @
Soft tissue sarcoma treatment market is in growing stage as very fewer products in the market are currently approved to treat various types of soft tissue sarcoma. Various international companies are very active in the soft tissue sarcoma treatment market in terms of product launches, research, and development activities. For instance, in 2012, Threshold Pharmaceuticals Inc. signed a global license and co-development agreement for Evofosfamide, which is the most advanced first-line drug for soft tissue sarcoma with Merck KGaA. Merck KGaA paid US$ 110 Mn as upfront payment and milestone payments to Threshold, and additionally, Merck KGaA covers 70% of all evofosfamide development expenses. GSK’s Votrient (pazopanib) is approved for second-line treatment, and another drug Aldoxorubicin is approved as first-line drug for the treatment of soft tissue sarcoma. Currently, doxorubicin is commonly used for the treatment of soft tissue sarcoma.
Need more information about this report @
Geographically, soft tissue sarcoma treatment market segmented into following regions Viz. North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America may lead the soft tissue sarcoma treatment market owing to increase in the prevalence of the disease. According to American Cancer Society, approximately 12,390 people in 2016 are suffering soft tissue sarcoma and cancer. Europe holds a key share in soft tissue sarcoma treatment market attributed to change in lifestyle, increase in R&D activities for the development of new drugs. Asia-Pacific region accounts for a significant growth due to increase in cancer cases, and rise in awareness about advanced soft tissue sarcoma treatment.
Some of the players in the soft tissue sarcoma treatment market are GlaxoSmithKline plc (U.K.), Eli Lilly and Company (U.S.), Pfizer, Inc. (U.S.), Bristol-Myers Squibb (U.S.), F. Hoffmann-La Roche AG (Genentech) (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Teva Pharmaceutical Industries Ltd (Israel), and Celgene Corporation (U.S.) to name a few.
Get access to full summary @
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
Smoking Cessation and Nicotine De addiction Products Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
By Product Type (Nicotine Based Products (Nicotine Gums, Nicotine Patches, Nicotine Sprays, Nicotine Inhalers, and Nicotine Lozenges) Electronic Cigarette, and Non-nicotine Products (Varenicline, Bupropion, Cytisine)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Retail Stores), and Geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
Global Smoking Cessation and Nicotine De-addiction Products Market Report Description:
Global Smoking Cessation and Nicotine De-addiction Products Market report gives a comprehensive outlook on smoking cessation & nicotine de-addiction products across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on smoking cessation & nicotine de-addiction products market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, distribution channel, and geographic regions. This report studies smoking cessation & nicotine de-addiction products market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, smoking cessation & nicotine de-addiction products market report includes new product introductions; regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed smoking cessation & nicotine de-addiction products market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the smoking cessation & nicotine de-addiction products market report include suppliers, manufacturers, marketers, policymakers, and healthcare service providers engaged in manufacturing, supply and prescription of Smoking Cessation and Nicotine De-addiction Products Market
A sample of this report is available upon request @
Global Smoking Cessation and Nicotine De-addiction Products Market:
Global Smoking Cessation and Nicotine De-addiction Products Market estimated to be valued US$ 9,014 Mn in 2017 and poised to grow at CAGR of 12.7% over 2017-2023. The market for smoking cessation & nicotine de-addiction products projected to reach US$ 18,489 Mn by 2023 owing to growing awareness regarding smoking cessation and availability of wider product choices.
Do policy changes bring positive impact on smoking cessation and nicotine de-addiction products market?
Of late, several governments across the globe coming up with policy changes to curb the smoking habit among people, which is likely to prompt smokers to adopt alternatives to smoking such as nicotine-based products or E-cigarettes. Moreover, several governments are launching innovative awareness campaigns through digital, electronic and print media to sensitize the people regarding harmful effects of the smoking. These government initiatives expected to drive the market for smoking cessation & nicotine de-addiction products over the forecast period. For Instance, countries/regions like China, India and GCC countries brought laws that mandate the tobacco products manufacturers to place warning labels on the products and same laws prohibit the smoking in public areas, these are expected to create a market opportunity for the players.
To view TOC of this report is available upon request @
Growing adoption of smoking cessation and nicotine de-addiction products across the globe is creating significant market opportunities
The growing prevalence of smoking and its hazardous effects on the cardiac and respiratory system is driving the smokers to adopt an alternative to smoking like nicotine-based products and E-cigarettes, this is expected to create a huge growth opportunity for market players over the forecast period. Moreover, consumers have been exposed to numerous innovative products in different formulations, which are helping buyers to choose the appropriate product for consumption, this in turn aiding the product adoption in the market. Moreover, regulatory approvals for Nicotine Replacement Therapies (NRT), non-nicotine based products and e-cigarettes are aiding the market revenue growth.
North America emerged as prominent region for smoking cessation & nicotine de-addiction products market across the globe
North America market is expected to hold the larger revenue share in global smoking cessation & nicotine de-addiction products market and projected to remain dominant over the forecast period owing to growing awareness and wider adoption choices in the region. Asia-pacific Smoking cessation & nicotine de-addiction products market projected to grow at highest CAGR over the forecast period in comparison with other regions owing to large smoking population and growing interest of multinational players in the region for geographic expansion.
Need more information about this report @
Competition Assessment
Key players profiled in the global Smoking Cessation & Nicotine De-addiction Products Market include:
- Cipla Ltd. (India)
- GlaxoSmithKline plc. (UK)
- ITC Limited (India)
- Johnson & Johnson Services Inc. (U.S)
- NJOY, Inc. (U.S)
- Novartis AG (Switzerland)
- Pfizer, Inc. (U.S)
- Takeda Pharmaceuticals Co. Ltd. (Japan)
- VMR Products, LLC (U.S)
Players in smoking cessation & nicotine de-addiction products market are focusing on introducing newer and innovative therapies like varenicline and Cytisine to garner larger market revenue share in global smoking cessation & nicotine de-addiction products market. Moreover, players entering into collaborations and partnership to increase the product market reach in various geographies
Get access to full summary @
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised which follow a holistic approach to solve needs of market research services based on our client needs.
Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
Global Smart Wound Care Products Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2024
Global Smart Wound Care Products market are sterile compressor pad which is applied to a wound to help promote healing and protect from further harm. Apart from promoting healing, wound care products helps in clotting to stop bleeding, absorb excessive fluids, wound debridement etc. Smart care products is an advanced wound care method which avoids the manual removing of care products and physical inspection of wounds to promote further care of the patient. These smart wound care products help in monitoring patient wound conditions like temperature, pH, and moisture. With these smart wound care products, healthcare professionals can be alerted to the possible presence of infections or other healing issues through the wireless network. These smart wound devices avert the possible infections by sending alert signals via electronic transmission of signals or changing the color of the care products.
Increasing incidence of chronic wounds in developing and developed economies, rising costs of wound management, increasing number of aging population in developed markets and Advantages associated with the use of smart wound care products like patient comforts, cost-effectiveness expected to drive the market for Global Smart Wound Care products Market over the forecast period. Moreover, smart care products generate significant cost savings, due to the reduced hospital stay and clinical inspection time result of faster healing which contribute to boosting market revenue for smart wound care products in the market. For instance, in the UK alone, around 200,000 patients are treated for chronic wounds yearly at an estimated annual cost of £4 billion this signifies the need effective healing strategies for wounds in patients. However, higher prices of smart wound care products, the dearth of product availability and accessibility may hamper the market revenue growth of smart wound care products market over the forecast period.
Smart wound care products market has been segmented on the basis of product type, material type, end user, and region
A sample of this report is available upon request @
Smart wound care products market has been segmented on the basis of product type, material type, end user, and region
Based on product type, Smart wound care products market segmented as follows:
- Wound Dressings
- Bandages
- Others
Based on material type, Smart wound care products market segmented as follows:
- Smart Polymers
- Textile Based
Based on distribution channel, Smart wound care products market segmented as follows:
- Hospitals
- Clinics
- Homecare Settings
- E-Commerce
To view TOC of this report is available upon request @
Players in smart wound care research arena collaborating with research institutes and innovation centres to come up with innovative products for smart wound care. For instance in 2015, Holst Centre has teamed up with Ireland’s leading ICT research centre, Tyndall National Institute (Cork) and medical equipment provider Fleming Medical (Limerick) to develop the world’s first commercially-available “smart care products” for use in futuristic wound care applications. Other players developing self regulating care products with smart polymers to fasten the healing process. For instance, OSNovative Systems, Inc. developed ENLUXTRA, a smart wound care products is the first and only self-regulating super-absorbent fiber wound care products with the highest adaptive absorbency and built-in adaptive hydration function.
Need more information about this report @
Market opportunity for smart wound care products market has been segmented into five regions Viz. North Americas, Europe, Asia Pacific, Latin America and Middle East and Africa. Players in Europe market involved in developing innovative smart wound healing products. For instance Netherland’s Holst centre developing DermaTrax’, contains sensors that monitor conditions in a patient’s wound, including its temperature, moisture and pH. North America market expected to witness positive growth for smart wound care products owing to favorable reimbursement policies. For instance, Enluxtra has HCPCS reimbursement codes: A6196, A6197, and A6198, Covered when used for wounds with moderate or high exudates. Asia pacific market expected to witness significant growth owing to increasing incidence of chronic wounds owing rising prevalence of Diabetic Foot Ulcer (DFU), rising incidences of injuries and ageing population in Japan expected to drive the market for smart wound care products.
Some of the players in the Smart wound care products market include OSNovative Systems, Inc., and Derma Sciences, Inc. to name a few.
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-smart-wound-care-products-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised which follow a holistic approach to solve needs of market research services based on our client needs.
Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.
Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
